Key statistics
As of last trade, Dr Reddy's Laboratories Ltd (RDDA:STU) traded at 13.20, 10.92% above the 52 week low of 11.90 set on Dec 12, 2023.
52-week range
Open | 13.30 |
---|---|
High | 13.30 |
Low | 13.20 |
Bid | 13.10 |
Offer | 13.60 |
Previous close | 13.30 |
Average volume | 382.22 |
---|---|
Shares outstanding | 833.05m |
Free float | -- |
P/E (TTM) | 18.48 |
Market cap | 11.80bn USD |
EPS (TTM) | 0.757 USD |
Annual div (ADY) | 0.0881 EUR |
---|---|
Annual div yield (ADY) | 0.67% |
Div ex-date | Jul 30 2024 |
Div pay-date | Aug 12 2024 |
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Press releases
- Dr. Reddy’s Q2 & H1FY25 Financial Results
- Dr. Reddy's Named by Science Magazine in Top 20 Global Pharma Employers List for Third Consecutive Year
- Dr. Reddy’s Launches Comprehensive Menopause Support Program and Training for Employees During Menopause Awareness Month
- Aurigene Oncology Limited Announces Promising Results of Phase 1 Study for India’s First Trial for Novel Autologous CAR-T Cell Therapy for Multiple Myeloma
- Dr. Reddy’s signs voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countries
More ▼